Yaoqin Gong Selected Research

Colonic Neoplasms (Colon Cancer)

2/2020	CUL4B contributes to cancer stemness by repressing tumor suppressor miR34a in colorectal cancer.
1/2016	GSH-dependent antioxidant defense contributes to the acclimation of colon cancer cells to acidic microenvironment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yaoqin Gong Research Topics

Disease

33	Neoplasms (Cancer) 01/2024 - 11/2010
6	Breast Neoplasms (Breast Cancer) 06/2023 - 10/2012
6	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 10/2012
5	Neoplasm Metastasis (Metastasis) 06/2023 - 10/2012
5	Asthma (Bronchial Asthma) 11/2015 - 01/2007
4	Inflammation (Inflammations) 01/2021 - 11/2015
4	Atherosclerosis 11/2015 - 03/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 02/2020
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 02/2015
3	X-Linked Mental Retardation (Mental Retardation, X Linked) 01/2020 - 03/2007
3	Carcinogenesis 07/2016 - 01/2011
3	Muscular Diseases (Myopathy) 06/2013 - 10/2012
2	Septic Shock (Toxic Shock Syndrome) 01/2023 - 01/2021
2	Insulin Resistance 01/2022 - 01/2017
2	Infections 01/2022 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 02/2020 - 01/2016
2	Genomic Instability 01/2020 - 04/2011
2	Obesity 11/2019 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2019 - 11/2010
2	Hereditary Spastic Paraplegia 01/2017 - 03/2013
2	Hepatocellular Carcinoma (Hepatoma) 04/2015 - 06/2012
2	Intellectual Disability (Idiocy) 05/2013 - 03/2013
2	Osteosarcoma (Osteogenic Sarcoma) 02/2012 - 03/2009
1	Pathologic Processes 01/2024
1	Peritonitis 01/2023
1	Body Weight (Weight, Body) 01/2022
1	Acidosis 01/2021
1	Glioma (Gliomas) 01/2021
1	Oculocerebrorenal Syndrome (Lowe Syndrome) 01/2021
1	Tremor (Tremors) 01/2020
1	Delayed Puberty 01/2020
1	Metabolic Diseases (Metabolic Disease) 11/2019
1	Wounds and Injuries (Trauma) 11/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Glucose Intolerance 06/2017
1	Leukemia 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2015

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2005
9	Cullin Proteins (Cullins)IBA 01/2021 - 03/2007
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 09/2011
5	Ligases (Synthetase)IBA 01/2021 - 03/2007
5	UbiquitinIBA 01/2021 - 03/2007
5	BerberineIBA 10/2017 - 03/2009
5	AlkaloidsIBA 10/2017 - 03/2009
4	AntioxidantsIBA 01/2021 - 01/2016
4	MicroRNAs (MicroRNA)IBA 07/2015 - 01/2011
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2024 - 12/2015
3	CaspasesIBA 06/2023 - 01/2023
3	p38 Mitogen-Activated Protein KinasesIBA 01/2023 - 02/2012
3	Biomarkers (Surrogate Marker)IBA 06/2019 - 04/2011
3	CateninsIBA 12/2015 - 04/2015
2	LipopolysaccharidesIBA 01/2023 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2022
2	Therapeutic UsesIBA 01/2022 - 10/2017
2	Superoxides (Superoxide)IBA 01/2022 - 01/2020
2	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 02/2015
2	Tamoxifen FDA LinkGeneric 01/2021 - 01/2015
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2019 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 02/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018 - 10/2017
2	ResveratrolIBA 01/2017 - 11/2010
2	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2017 - 12/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2013
2	oxidized low density lipoproteinIBA 11/2015 - 09/2015
2	LipidsIBA 11/2015 - 10/2012
2	Cysteine (L-Cysteine)FDA Link 07/2015 - 01/2005
2	neferineIBA 07/2015 - 02/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 10/2012
2	AcetylglucosamineIBA 01/2013 - 04/2011
2	Racemases and Epimerases (Epimerases and Racemases)IBA 01/2013 - 04/2011
2	N-acylmannosamine kinaseIBA 01/2013 - 04/2011
2	Uridine Diphosphate (UDP)IBA 01/2013 - 04/2011
1	Cadherins (E-Cadherin)IBA 06/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	CeramidesIBA 01/2022
1	Circular DNAIBA 01/2022
1	((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	RecQ HelicasesIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Inositol Polyphosphate 5-PhosphatasesIBA 01/2021
1	Poly I-CIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 03/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	ChromatinIBA 01/2020
1	matrigelIBA 11/2019
1	nutlin 3IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2019
1	niraparibIBA 10/2017
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2017
1	mouse MIRN194 microRNAIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 07/2016
1	InterferonsIBA 07/2016
1	alvocidib (flavopiridol)IBA 01/2016
1	Cyclin-Dependent Kinase 9IBA 01/2016
1	SphingolipidsIBA 11/2015

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2011
4	Drug Therapy (Chemotherapy) 06/2023 - 01/2011
2	Radiotherapy 01/2024 - 01/2011